Stem Cells

HighQC™ Human IPSC From Fibroblast-Amyotrophic Lateral Sclerosis

  • For research use only

Cat No.

ABC-SC0212

Product Type

Human iPSCs

Cell Type

Induced Pluripotent Stem Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Fibroblast

Disease

Amyotrophic Lateral Sclerosis

Storage

Liquid Nitrogen

HighQC™ Human ALS iPSC from fibroblasts express pluripotency markers,non-tumorigenic, suitable for ALS modeling,neural differentiation,and drug screening.

Product Image

Description

HighQC™ Human iPSC from Fibroblast–Amyotrophic Lateral Sclerosis (ALS) is a patient-derived induced pluripotent stem cell (iPSC) line reprogrammed from dermal fibroblasts of individuals with ALS. These cells exhibit typical iPSC morphology with high nucleus-to-cytoplasm ratio, prominent nucleoli, and tight colony formation. Reprogrammed using non-integrating methods, they express core pluripotency markers such as OCT4, SOX2, and NANOG. Karyotype analysis indicates a normal diploid karyotype. They can be differentiated into neural and glial lineages to replicate disease-relevant phenotypes in vitro, making them suitable for investigating disease mechanisms and neurodegeneration.

Product Code

HighQC™ Human IPSC From Fibroblast-Amyotrophic Lateral Sclerosis, Human iPSC-Fibroblast-ALS, hIPSC-F-ALS, Human Fibroblast Derived iPSC ALS

Species

Human

Cat.No

ABC-SC0212

Product Category

Stem Cells

Size/Quantity

1 vial

Cell Type

Induced Pluripotent Stem Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Fibroblast

Disease

Amyotrophic Lateral Sclerosis

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Human iPSCs

Application

  • HighQC™ Human iPSC from Fibroblast–Amyotrophic Lateral Sclerosis (ALS) serve as a powerful tool for modeling amyotrophic lateral sclerosis in vitro. They can be differentiated into motor neurons, astrocytes, or oligodendrocytes to study cell-type-specific pathology, gene expression, and neurotoxicity. These cells are also valuable for drug screening, gene-editing validation, and personalized therapeutic development. ALS patient-derived iPSCs enable exploration of disease progression, neuroinflammation, and cellular stress mechanisms within a patient-specific genetic context.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring HighQC™ Human IPSC From Fibroblast-Amyotrophic Lateral Sclerosis

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button